Skip to main content
Clinical Trials/NCT05408195
NCT05408195
Withdrawn
N/A

Evaluate E-Care Acceptability for Older People Undergoing Chemotherapy at Home

University Hospital, Toulouse1 site in 1 countryJanuary 1, 2024
ConditionsCancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer
Sponsor
University Hospital, Toulouse
Locations
1
Primary Endpoint
Acceptance of semi-automated follow-up
Status
Withdrawn
Last Updated
last year

Overview

Brief Summary

The main objective of this pilot study is to evaluate the acceptability of clinical data collection using a semi-automated e-solution based on the use of text messaging among older adults undergoing chemotherapy treatment at home.

Detailed Description

Most cancer diagnosis are made among the 70 years and over population. In this population, negative consequences of cancer treatments are of great concern, especially for those who are socially isolated or live in rural areas. International oncology societies recommend personalized treatments to reduce adverse events. However, few tools have been validated in this population to monitor compliance and risks of outpatient treatments. In addition, health professionals continue to manage unplanned patient calls which could disrupt effectiveness of their work. Our hypothesis is that the semi-automated collection of health data (text message questionnaires) during outpatient chemotherapy secures the patient's care pathway and optimizes care time, in particular for patients' education and support. Therefore, patients (and/or their caregivers) who benefit from calls follow-up (usual care), would have the possibility of receiving an additional weekly remote questionnaire (by email or SMS) via a CHATBOT on any terminal. This automated questionnaire collects data on tolerance and compliance with care plan.

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
January 1, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects of 70 years of age or older;
  • Subjects undergoing chemotherapy treatment after a cancer diagnosis;
  • Subjects managed by the oncogeriatrics team at the Toulouse University Hospital as part of an outpatient follow-up and followed by conventional telephone calls and CHATBOT support.

Exclusion Criteria

  • Patient's refusal to participate.
  • Patient does not have sufficient equipment for downloading and using the CHATBOT tool
  • Participant under guardianship, curatorship or safeguard of justice.

Outcomes

Primary Outcomes

Acceptance of semi-automated follow-up

Time Frame: 6 months of CHATBOT use

Proportion of patients who uploaded the application, Proportion of patients who received at least one questionnaire, Proportion of patients who answered at least one questionnaire, Completion questionnaire rate and answered questionnaire rate

Study Sites (1)

Loading locations...

Similar Trials